| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Jan―13 |
Model for predicting the severity and outcome of COVID-19 in patients with diabetes mellitus and obesity, created based on artificial intelligence methods |
Aramisova L.S. Aramisova, Zhurtova I.B. Zhurtova, Akhkubekova Z.A. Akhkubekova |
| 2 |
[GO] |
2024―Nov―26 |
Association between CES1, CYP3A genetic polymorphisms and remdesivir hepatotoxicity in patients with COVID-19 |
Temirbulatov I.I. Temirbulatov, Abdullaev Sh.P. Abdullaev, Denisenko N.P. Denisenko, Kryukov A.V. Kryukov, Tuchkova S.N. Tuchkova, Mirzaev K.B. Mirzaev, et al. (+3) Averkov O.V. Averkov, Vechorko V.I. Vechorko, Sychev D.A. Sychev |
| 3 |
[GO] |
2024―Nov―26 |
The course of chronic spontaneous urticaria in patients with COVID-19: analysis of clinical cases |
Peredelskaya M.Yu. Peredelskaya, Sebekina O.V. Sebekina, Nenasheva N.M. Nenasheva |
| 4 |
[GO] |
2024―Sep―10 |
Dynamics of symptoms in outpatients with SARS-CoV2 infection |
Bontsevich R.A. Bontsevich, Zhdanova Zh.S. Zhdanova, Ryabchikova A.A. Ryabchikova, Solovyova L.V. Solovyova, Vovk Ya.R. Vovk, Dauletova Z.D. Dauletova, et al. (+2) Ponomarenko T.N. Ponomarenko, Maksimov M.L. Maksimov |
| 5 |
[GO] |
2024―Apr―23 |
Association of N-terminal pro C-type natriuretic peptide and endothelin-1 levels with the risk of cardiovascular complications in arterial hypertension six months after COVID-19 |
Shuvalova A.S. Shuvalova, Prokofieva T.V. Prokofieva, Polunina O.S. Polunina, Polunina E.A. Polunina |
| 6 |
[GO] |
2024―Apr―23 |
Determinants of development, prediction and prevention of professional burnout in nurses during the COVID-19 pandemic |
Babanov S.A. Babanov, Ostryakova N.A. Ostryakova, Strizhakov L.A. Strizhakov, Melentyev A.V. Melentyev, Lysova M.V. Lysova |
| 7 |
[GO] |
2024―Apr―23 |
Epidemiological characteristics of respiratory infections during the last autumn-winter season of the COVID-19 pandemic according to data from a repurposed children’s hospital |
Zaytseva O.V. Zaytseva, Tolstova E.M. Tolstova, Zaitseva N.S. Zaitseva, Lokshina E.E. Lokshina, Abaseeva T.Yu. Abaseeva, Bagirova N.I. Bagirova, et al. (+15) Bardenikova S.I. Bardenikova, Besedina M.V. Besedina, Bogdanova N.A. Bogdanova, Kuznetsov G.B. Kuznetsov, Mstislavskaya S.A. Mstislavskaya, Ostroukhova I.P. Ostroukhova, Rychkova T.I. Rychkova, Serebrovskaya N.B. Serebrovskaya, Striga E.V. Striga, Shavlokhova L.A. Shavlokhova, Shiro- nina N.V. Shiro-, Nikonova M.A. Nikonova, Kuzina S.R. Kuzina, Efimova E.V. Efimova, Belyaeva T.Yu. Belyaeva |
| 8 |
[GO] |
2024―Apr―23 |
Correction of cognitive impairment associated with age-dependent cerebral microangiopathy after COVID-19 using the combination drug vinpocetine+piracetam: clinical case report |
Vorob’eva O.V. Vorob’eva |
| 9 |
[GO] |
2024―Apr―19 |
Problems of managing patients with COPD in the post-pandemic waves of COVID-19 |
Yu.G. Belotserkovskaya Belotserkovskaya, A.G. Romanovskikh Romanovskikh, I.P. Smirnov Smirnov |
| 10 |
[GO] |
2024―Apr―19 |
Key aspects of cardiovascular damage in COVID-19 |
V.V. Salukhov Salukhov, B.V. Sagun Sagun |
| 11 |
[GO] |
2024―Apr―19 |
On certain problems of diagnosis, treatment and prospects for the rehabilitation of patients with circulatory diseases after coronavirus infection COVID-19 (literature review) |
E.I. Bugaeva Bugaeva, K.V. Zhmerenetsky Zhmerenetsky, S.V. Dyachenko Dyachenko |
| 12 |
[GO] |
2024―Apr―19 |
Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection |
I.B. Zhurtova Zhurtova, A.M. Gubachikova Gubachikova, L.S. Aramisova Aramisova, H.A. Abdul Moati Abdul, L.A. Anaeva Anaeva |
| 13 |
[GO] |
2024―Apr―19 |
Features of compensation of carbohydrate metabolism in patients with type 2 diabetes mellitus hospitalized with coronavirus infection |
T.N. Markova Markova, A.A. Anchutina Anchutina, M.S. Stas Stas, M.M. Medzhidova Medzhidova |
| 14 |
[GO] |
2024―Apr―19 |
Diabetes mellitus and new coronavirus infection: a look into the past, conclusions on prevention and treatment tactics for the future |
L.S. Aramisova Aramisova, I.B. Zhurtova Zhurtova, A.M. Gubachikova Gubachikova |
| 15 |
[GO] |
2023―Apr―24 |
Features of the pathogenesis of thyroid diseases in COVID-19 |
O.V. Maksim Maksim, B.V. Romashevsky Romashevsky, N.Yu. Demyanenko Demyanenko |
| 16 |
[GO] |
2023―Apr―21 |
Respiratory infections during the COVID-19 pandemic - what has changed? |
S.V. Nikolaeva Nikolaeva, E.K. Shushakova Shushakova |
| 17 |
[GO] |
2023―Feb―03 |
The prevalence and features of professional burnout among medical workers during the pandemic of a new coronavirus infection COVID-19 |
S.A. Babanov Babanov, N.E. Lavrentieva Lavrentieva, T.A. Azovskova Azovskova, N.A. Ostryakova Ostryakova |
| 18 |
[GO] |
2023―Feb―03 |
Exogenous glucocorticoids and the platelet component of the hemostasis system in COVID-19 |
N.V. Izmozherova Izmozherova, A.A. Popov Popov, I.P. Antropova Antropova, L.I. Kadnikov Kadnikov, Ya.V. Livshits Livshits, A.D. Kushtyeva Kushtyeva, et al. (+3) A.A. Nikonova Nikonova, V.M. Bakhtin Bakhtin, M.A. Shambatov Shambatov |
| 19 |
[GO] |
2023―Feb―03 |
Features of adaptation of medical students to the conditions of online education during the COVID-19 pandemic |
T.I. Bonkalo Bonkalo, S.V. Shmeleva Shmeleva, S.B. Kachalov Kachalov, M.V. Eremin Eremin, E.E. Ivashkova Ivashkova |
| 20 |
[GO] |
2023―Feb―03 |
Features of the pathogenesis and treatment of diabetes mellitus during the COVID-19 pandemic |
A.E. Bagriy Bagriy, E.S. Mikhailichenko Mikhailichenko, A.V. Prikolota Prikolota, K.E. Mogilevskaya Mogilevskaya |
| 21 |
[GO] |
2023―Feb―03 |
Psoriasis, metabolic syndrome and COVID-19: a case report |
I.S. Vladimirova Vladimirova |
| 22 |
[GO] |
2023―Feb―03 |
Pediatric inflammatory multisystem syndrome associated with COVID-19: a clinical case |
O.A. Bashkina Bashkina, I.V. Vyazovaya Vyazovaya, D.F. Sergienko Sergienko |
| 23 |
[GO] |
2023―Feb―03 |
Preferences of Belgorod primary care phycisians in the treatment of a new coronavirus infection |
R.A. Bontsevich Bontsevich, Ya.R. Vovk Vovk, V.A. Vinyukov Vinyukov, D.G. Dubonosova Dubonosova |
| 24 |
[GO] |
2023―Feb―03 |
Features of the clinical course of a new coronavirus infection in children |
A.A. Turovskaya Turovskaya, E.M. Kostina Kostina, E.A. Orlova Orlova, E.Yu. Trushina Trushina, G.M. Grishanovich Grishanovich, O.G. Sidorova Sidorova, E.V. Avdoshina Avdoshina |
| 25 |
[GO] |
2023―Feb―03 |
Proadrenomedullin levels and clinical features of SARS-CoV-2 coronavirus infection: a prospective clinical study |
A.A. Astapovsky Astapovsky, V.N. Drozdov Drozdov, E.V. Shikh Shikh, N.B. Lazareva Lazareva, G.G. Melkonyan Melkonyan, A.A. Meshcheryakov Meshcheryakov, E.V. Tsepkova Tsepkova |
| 26 |
[GO] |
2023―Jan―31 |
A comorbid patient at a therapeutic reception during the COVID-19 pandemic. Current aspects of the rehabilitation period |
D.I. Trukhan Trukhan |
| 27 |
[GO] |
2022―Mai―16 |
Features of the management and follow-up of a “difficult” comorbid elderly patient with COVID-19 complications: a clinical case |
A.V. Tarantsova Tarantsova |
| 28 |
[GO] |
2022―Mrz―02 |
Manifestation of primary adrenal insufficiency in a child against the background of a novel coronovirus infection COVID-19: a clinical case |
I.B. Zhurtova Zhurtova, M.A. Elgarova Elgarova, A.M. Gubachikova Gubachikova, M.R. Kurashinova Kurashinova |
| 29 |
[GO] |
2022―Feb―24 |
The place and role of a therapist and general practitioner in the management of comorbid patients during the pandemic of the new coronavirus infection (COVID-19): an emphasis on the rehabilitation stage |
D.I. Trukhan Trukhan, E.L. Davydov Davydov |
| 30 |
[GO] |
2022―Feb―24 |
Antiarrhythmic therapy for atrial fibrillation in patients with the novel SARS-CoV-2 coronavirus infection: how to make the right choice? |
A.I. Tarzimanova Tarzimanova, E.E. Bykova Bykova |
| 31 |
[GO] |
2021―Dez―13 |
Possibility and prospects for the use of recombinant neutralizing monoclonal antibodies (bamlanivimab+etesevimab, sotrovimab) in patients with COVID-19 |
V.M. Tsvetov Tsvetov, I.S. Burashnikova Burashnikova, D.A. Sychev Sychev |
| 32 |
[GO] |
2021―Nov―09 |
Potentials for the use of glucocorticosteroids in inpatients with severe COVID-19 |
V.M. Tsvetov Tsvetov, A.V. Matveev Matveev, K.B. Mirzaev Mirzaev, V.A. Otdelnov Otdelnov, D.A. Sychev Sychev |
| 33 |
[GO] |
2021―Nov―09 |
Medical rehabilitation and sanatorium-resort treatment of patients with new coronavirus infection COVID-19 |
A.B. Achabaeva Achabaeva, D.A. Teuvazhukova Teuvazhukova, F.A. Kuchmezova Kuchmezova, I.A. Kalmykov Kalmykov, I.Kh. Gelyastanov Gelyastanov |
| 34 |
[GO] |
2021―Nov―09 |
The place and role of a therapist and general practitioner in the management of comorbid patients during the pandemic of the new coronavirus infection (COVID-19): an emphasis on non-specific prevention |
D.I. Trukhan Trukhan, E.L. Davydov Davydov |
| 35 |
[GO] |
2021―Aug―19 |
On the dermatological aspects of the novel coronavirus infection (COVID-19) |
I.V. Kosheleva Kosheleva, O.A. Bitkina Bitkina, L.I. Shadyzheva Shadyzheva, O.V. Andriyakhina Andriyakhina, A.Yu. Nikolaeva Nikolaeva, M.N. Fyrnina Fyrnina, et al. (+4) M.A. Deryavaya Deryavaya, K.S. Pershina Pershina, D.S. Zueva Zueva, A.A. Tsyganova Tsyganova |
| 36 |
[GO] |
2021―Aug―19 |
The rationale for the combined use of genetically engineered biological drugs in patients with COVID-19 |
I.S. Burashnikova Burashnikova |
| 37 |
[GO] |
2021―Aug―19 |
The rationale for re-administration of genetically engineered biological drugs in patients with COVID-19 |
I.S. Burashnikova Burashnikova |
| 38 |
[GO] |
2021―Jul―15 |
Skin lesions associated with new coronavirus infection (COVID-19) |
I.V. Kosheleva Kosheleva, O.A. Bitkina Bitkina, L.I. Shadyzheva Shadyzheva, A.Yu. Nikolaeva Nikolaeva, O.V. Andriyakhina Andriyakhina, O.A. Pankova Pankova, et al. (+2) E.S. Udalova Udalova, A.A. Tsyganova Tsyganova |
| 39 |
[GO] |
2021―Jun―21 |
Scientific rationale and prerequisites for the use of direct oral anticoagulants for the prevention of thromboembolic complications in patients with COVID-19 |
V.A. Otdelenov Otdelenov, A.V. Matveev Matveev, K.B. Mirzaev Mirzaev, D.A. Sychev Sychev |
| 40 |
[GO] |
2021―Jun―21 |
Patients with bronchial asthma who have undergone COVID-19 |
E.Yu. Trushina Trushina, E.M. Kostina Kostina, E.A. Orlova Orlova |
| 41 |
[GO] |
2021―Jun―21 |
Clinical and pharmacological aspects of the use of drugs for COVID-19 in pregnant women |
V.M. Tsvetov Tsvetov, K.B. Mirzaev Mirzaev |
| 42 |
[GO] |
2021―Jun―21 |
New coronavirus infection COVID-19 in pregnant women: epidemiology, course, outcomes, prevention options |
T.E. Belokrinitskaya Belokrinitskaya, N.V. Artymuk Artymuk, O.S. Filippov Filippov, N.I. Frolova Frolova |
| 43 |
[GO] |
2021―Jun―21 |
The new COVID-19 virus and its impact on female sexual dysfunction |
M.N. Surina Surina, N.V. Artymuk Artymuk, A.V. Atalyan Atalyan, M. Al-Jefout Al-Jefout, O.O. Chernova Chernova |
| 44 |
[GO] |
2021―Jun―21 |
Experience of SLIT in patients with bronchial asthma through the prism of the coronavirus infection pandemic |
E.A. Orlova Orlova, E.M. Kostina Kostina, E.Yu. Trushina Trushina |
| 45 |
[GO] |
2021―Jun―21 |
The structure of the mRNA molecule in vaccines for the prevention of SARS-CoV-2 infection - not so simple |
A.V. Veselov Veselov |
| 46 |
[GO] |
2021―Apr―09 |
The role of metabolic drugs in the complex therapy of acute cerebrovascular accidents in patients with coronavirus infection COVID-19 |
E.B. Kuznetsova Kuznetsova, I.V. Sitkali Sitkali, O.V. Kolokolov Kolokolov, E.B. Likhacheva Likhacheva, A.M. Kolokolova Kolokolova, M.A. Polidanov Polidanov, A.R. Vasilieva Vasilieva |
| 47 |
[GO] |
2021―Apr―09 |
The role and place of telemedicine technologies in the rehabilitation of stroke patients in the context of the COVID-19 pandemic |
I.P. Parfenov Parfenov, R.V. Shirokiy Shirokiy, V.S. Fomin Fomin |
| 48 |
[GO] |
2021―Apr―05 |
Predictors of severe course of disease and high mortality among patients with COVID-19 and diabetes mellitus |
M.Z. Ivanova Ivanova, I.B. Zhurtova Zhurtova, S.Kh. Sizhazheva Sizhazheva, A.M. Gubachikova Gubachikova |
| 49 |
[GO] |
2021―Apr―01 |
Scientific prerequisites and prospects for the use of sildenafil in patients with COVID-19 |
V.M. Tsvetov Tsvetov, A.V. Matveev Matveev |
| 50 |
[GO] |
2021―Apr―01 |
Possibility and prospects of using colchicine in patients with COVID-19, review update |
Yu.Yu. Kiselev Kiselev, A.V. Matveev Matveev |
| 51 |
[GO] |
2021―Mrz―10 |
Evaluation of the scientific basis for the use of riamilovir for the treatment of COVID-19 |
K.B. Mirzaev Mirzaev, V.M. Tsvetov Tsvetov |
| 52 |
[GO] |
2021―Mrz―10 |
Possibility and prospects of using bamlanivimab in patients with COVID-19 |
K.B. Mirzaev Mirzaev, D.A. Sychev Sychev |
| 53 |
[GO] |
2021―Mrz―10 |
Typical changes in the lungs of children with covid-19, atypical treatment |
A.S. Polyakova Polyakova, M.D. Bakradze Bakradze, I.L. Mityushin Mityushin, I.L. Chashchina Chashchina, A.A. Tkacheva Tkacheva |
| 54 |
[GO] |
2021―Mrz―10 |
The possibility and prospects of using cytostatics in patients with COVID-19 on the example of cyclophosphamide |
V.M. Tsvetov Tsvetov, I.S. Burashnikova Burashnikova, D.A. Sychev Sychev, I.V. Poddubnaya Poddubnaya |
| 55 |
[GO] |
2020―Dez―08 |
Possibilities of using glucocorticosteroids in the outpatient treatment of patients with COVID-19 |
Yu.Yu. Kiselev Kiselev, K.B. Mirzaev Mirzaev |
| 56 |
[GO] |
2020―Dez―08 |
Scientific rationale for the use of remdesivir in patients with COVID-19 |
K.B. Mirzaev Mirzaev, V.M. Tsvetov Tsvetov |
| 57 |
[GO] |
2020―Dez―08 |
Drug therapy for asymptomatic carriers of SARS-CoV-2 |
I.S. Burashnikova Burashnikova, V.M. Tsvetov Tsvetov |
| 58 |
[GO] |
2020―Nov―02 |
Analysis of the incidence of new coronavirus infection in oncological patients on the example of the oncological department of anticancer drug therapy of the Bashkir State Medical University |
N.O. Yuldasheva Yuldasheva, R.I. Kunafina Kunafina, D.D. Sakaeva Sakaeva, D.E. Baykov Baykov, R.R. Suleymanova Suleymanova |
| 59 |
[GO] |
2020―Sep―25 |
Treatment of a new coronavirus infection (COVID-19): opportunities and limitations |
O.V. Fesenko Fesenko, O.A. Sibiryakova Sibiryakova, S.N. Shvayko Shvayko |
| 60 |
[GO] |
2020―Sep―25 |
Therapeutic and diagnostic aspects of the new coronavirus infection COVID-19 in obstetric practice |
E.I. Kakhiani Kakhiani, N.A. Korobkov Korobkov, V.V. Vasiliev Vasiliev, E.S. Romanova Romanova |
| 61 |
[GO] |
2020―Sep―25 |
Algorithm of respiratory support for COVID-19 patients |
S.L. Babak Babak, M.V. Gorbunova Gorbunova, A.G. Malyavin Malyavin |
| 62 |
[GO] |
2020―Sep―25 |
Review of clinical guidelines for the treatment of children with confirmed coronavirus infection COVID-19: a clinical pharmacologist’s view |
S.B. Erofeeva Erofeeva, E.P. Smirnova Smirnova |
| 63 |
[GO] |
2020―Sep―25 |
COVID-19: selected clinical aspects through the prism of practical experience |
Yu.G. Belotserkovskaya Belotserkovskaya, S.S. Lebedev Lebedev, D.V. Vakatov Vakatov, I.A. Demina Demina, O. N. Sakara Sakara, A.G. Romanovskikh Romanovskikh, I.P. Smirnov Smirnov |
| 64 |
[GO] |
2020―Sep―25 |
Clinical experience of sublingual allergen-specific immunotherapy of allergic rhinitis in a coronavirus pandemic |
E.A. Orlova Orlova, E.M. Kostina Kostina, O.A. Kulikova Kulikova |
| 65 |
[GO] |
2020―Aug―03 |
Skin lesions associated with new coronavirus infection (COVID-19) |
I.V. Kosheleva Kosheleva, O.A. Bitkina Bitkina, L.I. Shadyzheva Shadyzheva, A.Yu. Nikolaeva Nikolaeva, O.V. Andriyakhina Andriyakhina, O.A. Pankova Pankova, et al. (+2) E.S. Udalova Udalova, A.A. Tsyganova Tsyganova |
| 66 |
[GO] |
2020―Jun―09 |
“PharmaCOVID” - information center for pharmacotherapy of patients with new coronavirus infection COVID-19 |
D.A. Sychev Sychev, K.B. Mirzaev Mirzaev, D.V. Ivashchenko Ivashchenko, Yu.Yu. Kiselev Kiselev, V.A. Otdelenov Otdelenov, A.V. Kryukov Kryukov, et al. (+4) V.M. Tsvetov Tsvetov, K.A. Zagorodnikova Zagorodnikova, A.V. Matveev Matveev, S.V. Glagolev Glagolev |
| 67 |
[GO] |
2020―Jun―09 |
COVID-19: lessons we are learning today (as of April 27, 2020) |
Yu.G. Belotserkovskaya Belotserkovskaya, A.I. Sinopalnikov Sinopalnikov |
